Disclosure Of First-Time Adoption [Text Block]

Novonesis AS - Filing #1387164

Concept As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
Disclosure of first-time adoption [text block]
Disclosure of comparative information prepared under previous GAAP [text block]
Disclosure of comparative information prepared under previous GAAP [abstract]
Disclosure of comparative information prepared under previous GAAP [line items]
Equity
14,228,000,000 DKK
391,000,000 DKK
13,062,000,000 DKK
562,000,000 DKK
132,000,000 DKK
13,837,000,000 DKK
81,000,000 DKK
11,303,000,000 DKK
12,206,000,000 DKK
32,000,000 DKK
11,827,000,000 DKK
379,000,000 DKK
8,000,000 DKK
564,000,000 DKK
11,263,000,000 DKK
11,000,000 DKK
127,000,000 DKK
11,233,000,000 DKK
570,000,000 DKK
727,000,000 DKK
11,244,000,000 DKK
Comprehensive income
3,939,000,000 DKK
3,676,000,000 DKK
10,000,000 DKK
113,000,000 DKK
3,929,000,000 DKK
140,000,000 DKK
1,000,000 DKK
159,000,000 DKK
3,706,000,000 DKK
719,000,000 DKK
3,707,000,000 DKK
3,146,000,000 DKK
Profit (loss)
3,686,000,000 DKK
3,676,000,000 DKK
10,000,000 DKK
3,676,000,000 DKK
1,000,000 DKK
3,146,000,000 DKK
3,145,000,000 DKK
3,146,000,000 DKK

Talk to a Data Expert

Have a question? We'll get back to you promptly.